MicroMGx

MicroMGx is a United States-based biotechnology company headquartered in Chicago, Illinois. The company is a small enterprise with 6 employees and reported $2.5 million in revenue. MicroMGx specializes in the discovery and development of novel natural products. They leverage a unique approach that integrates metabolomics, genome sequencing, and bioinformatics, a methodology they pioneered and termed "metabologenomics." This innovative process enables them to identify and characterize thousands of new natural products from microbial strains provided by their clients. MicroMGx's primary focus is serving major pharmaceutical and agriculture companies. Their high-throughput discovery platform disrupts traditional natural product research paradigms, offering a faster, more efficient, and comprehensive approach to uncovering valuable compounds. By predicting the structures and activities of these novel products, MicroMGx empowers their clients to accelerate their research and development pipelines. For more information about MicroMGx and their services, please visit their website at micromgx.com.